WFA
GSK icon

Wipfli Financial Advisors’s GSK GSK Stock Holding History

Wipfli Financial Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$208K Buy
+6,953
New +$264K 0.01% 438

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Wipfli Financial Advisors's GSK Position: Q3 2022 in Review

Wipfli Financial Advisors opened a new position in GSK (GSK) in Q3 2022: 6,953 shares worth $208K. The stake represents 0.01% of the portfolio and ranks #438 among its holdings.

742 funds tracked by Wall St. Rank hold GSK as of Q3 2022.

  • Wipfli Financial Advisors held 6,953 shares of GSK worth $208K as of Q3 2022.
  • GSK was a new Wipfli Financial Advisors position in Q3 2022.
  • GSK made up 0.01% of Wipfli Financial Advisors's portfolio in Q3 2022, its #438 holding.
  • 742 funds tracked by Wall St. Rank held GSK as of Q3 2022.

Based on Wipfli Financial Advisors's 13F filing for Q3 2022, filed 26 Oct 2022.